Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$37.46 - $42.44 $30.9 Million - $35 Million
-824,033 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$35.17 - $42.48 $10.3 Million - $12.4 Million
-291,947 Reduced 26.16%
824,033 $32.8 Million
Q3 2021

Nov 15, 2021

BUY
$36.14 - $42.24 $33.1 Million - $38.7 Million
915,980 Added 457.99%
1,115,980 $40.3 Million
Q4 2020

Feb 10, 2021

SELL
$36.12 - $50.05 $33.1 Million - $45.8 Million
-915,980 Reduced 82.08%
200,000 $10 Million
Q2 2020

Aug 12, 2020

BUY
$44.5 - $52.11 $49.7 Million - $58.2 Million
1,115,980 New
1,115,980 $54.2 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.